A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis
- PMID: 11359139
- DOI: 10.1097/00005537-200104000-00021
A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis
Abstract
Purpose: A Swedish and Norwegian study was designed to examine health-related quality of life (HQL) in patients with head and neck cancer (head and neck) at diagnosis and during treatment and rehabilitation. The overall aim was to examine the impact on HQL at diagnosis depending on tumor location, stage, sex, and age (part I) and to describe HQL longitudinally and determine for which patients and during which period HQL deteriorated most (part II). This article presents the results at diagnosis.
Method: Patients with head and neck cancer at five hospitals in Sweden and Norway were consecutively requested to participate. They were asked to answer the EORTC QLQ-C30 and QLQ-H&N35 (the European Organization for Research and Treatment of Cancer, Core 30 questionnaire and head and neck cancer module) repeatedly during 1 year. A total of 357 patients (mean age, 63 y; 72% males) were included.
Results: Patients with different tumor locations all had their special problems at diagnosis, for example, those with tumors in the larynx with communication, those with oral tumors with pain, and those with pharyngeal tumors with nutrition and pain. The patients with hypopharyngeal cancer reported the worst HQL. Stage appeared to have the strongest impact on HQL. Patients with a more advanced tumor stage reported significantly worse HQL scores for 24 of 32 variables reflecting functioning or problems. The females scored worse than the males for some areas, in particular, emotional functioning. The older patients scored significantly better for emotional and social functioning than patients <65 years but worse for physical functioning and various symptoms. The traditional way of grouping the tumor locations into oral, pharyngeal, laryngeal, and "other" tumors (salivary gland, sinus and nose, and unknown primary) was tested from a HQL point of view and found to be consistent.
Conclusions: The chosen questionnaires differentiated between different sites of head and neck cancer at diagnosis. Tumor stage had the most powerful impact on HQL score.
Similar articles
-
Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms.Br J Cancer. 2001 Jan;84(2):149-56. doi: 10.1054/bjoc.2000.1576. Br J Cancer. 2001. PMID: 11161369 Free PMC article.
-
Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up.Head Neck. 2006 Apr;28(4):339-49. doi: 10.1002/hed.20334. Head Neck. 2006. PMID: 16287136
-
Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):772-8. doi: 10.1016/j.ijrobp.2008.05.001. Int J Radiat Oncol Biol Phys. 2009. PMID: 18676096
-
A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005.Oral Oncol. 2007 Oct;43(9):843-68. doi: 10.1016/j.oraloncology.2007.02.006. Epub 2007 Jun 27. Oral Oncol. 2007. PMID: 17600755 Review.
-
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase I.Head Neck. 2013 Sep;35(9):1331-8. doi: 10.1002/hed.23127. Epub 2012 Aug 21. Head Neck. 2013. PMID: 22907791 Review.
Cited by
-
Effectiveness of "OralDETECT": a Repetitive Test-enhanced, Corrective Feedback Method Competency Assessment Tool for Early Detection of Oral Cancer.J Cancer Educ. 2022 Apr;37(2):319-327. doi: 10.1007/s13187-020-01814-1. J Cancer Educ. 2022. PMID: 32821988
-
Comparative Analysis of the Quality of Life in the Pretreatment of Head and Neck Cancer Patients According to Tumor Site.Int Arch Otorhinolaryngol. 2022 Aug 1;27(1):e111-e116. doi: 10.1055/s-0042-1744168. eCollection 2023 Jan. Int Arch Otorhinolaryngol. 2022. PMID: 36714908 Free PMC article.
-
Stimulator of Interferon Genes Pathway Activation through the Controlled Release of STINGel Mediates Analgesia and Anti-Cancer Effects in Oral Squamous Cell Carcinoma.Biomedicines. 2024 Apr 21;12(4):920. doi: 10.3390/biomedicines12040920. Biomedicines. 2024. PMID: 38672274 Free PMC article.
-
Interaction of hope and optimism with anxiety and depression in a specific group of cancer survivors: a preliminary study.BMC Res Notes. 2011 Nov 28;4:519. doi: 10.1186/1756-0500-4-519. BMC Res Notes. 2011. PMID: 22123081 Free PMC article.
-
Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway.Pain. 2010 May;149(2):263-272. doi: 10.1016/j.pain.2010.02.010. Epub 2010 Mar 1. Pain. 2010. PMID: 20189717 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical